Dental Digital Workflow · SIX: STMN
Straumann Group: a dental ecosystem where 3D printing strengthens implants, prosthetics and chairside workflows rather than standing alone.
Straumann combines intraoral scanning, cloud connectivity, treatment planning, P and PRO series printers, validated resins, washing, curing and restorative or implant workflows. Its additive bottleneck is clinical integration, material validation and channel access—not printer hardware by itself.
As of: 28 October 2026 (key metrics updated to Q3 2026; other figures as of 18 July 2026) · Profile: Dental and medical AM workflow · Recommendation: None
Company Signal Monitor
LAST VERIFIED / REVIEWED
2026-10-28 (Q3 2026 key metrics; third-quarter release 28 October 2026)
NEXT CATALYST TO MONITOR
Serial production volumes, regulatory / customer adoption, workflow economics, recurring consumables and disclosed AM contribution.
Quick research snapshot
AM exposure: Medium
Pure-play score: 1 / 5
Bottleneck score: 4 / 5
Evidence: Qualified
Financial materiality: Emerging
Main risk: Dental demand, workflow adoption and fragmented lab economics.
Research verdict: Straumann combines scanners, software, printers, materials and implant workflows into a credible dental-production ecosystem; additive manufacturing supports platform stickiness but is not a separately disclosed earnings stream.
Investor read
Straumann accelerated organic growth again in the third quarter and confirmed its full-year 2026 outlook. Q3 2026 revenue reached CHF 667.1 million, representing 9.2% organic growth and a 10.8% increase in Swiss francs; nine-month revenue was CHF 2,046.5 million, up 8.3% organically. All regions contributed, with EMEA and APAC growing at double-digit organic rates.
Management continues to expect high-single-digit organic revenue growth for 2026 and confirmed core EBIT margin expansion of approximately 140–170 basis points at constant 2025 exchange rates, raised in June from the previous 30–60 basis-point range.
3D printing is strategically important because it increases in-house production, shortens treatment workflows and strengthens recurring resin and digital-service attachment. Financial materiality remains unknown: printer revenue, installed base, resin consumption, utilization and AM margins are not separately disclosed.
Subscribe to continue reading
Subscribe to get access to the rest of this post and other subscriber-only content.